IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. KRG
2. SPY
3. ALAR
4. CCH:LN
5. META
6. BAJAJHFL:I
7. CCHGY
8. PRY:IM
9. PRYMY
10. FFAI

Go back to IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Morgan Stanley Reiterates Overweight Rating on IGM Biosciences (IGMS)

August 14, 2024 12:04 PM EDT

Morgan Stanley analyst Michael Ulz reiterated an Overweight rating and $12.00 price target on IGM Biosciences (NASDAQ: IGMS)

The analyst comments "Reported 2Q24 highlighted progress across the early stage pipeline as Ph1b dose escalation continues for imvotamab in RA and... More